Senate Judiciary Committee Chairman Durbin, Senate Democrats Urge USPTO, Drug Companies To Address Errors In Patent Term Adjustment To Prevent Unwarranted Pharma Monopolies
September 19, 2024
September 19, 2024
WASHINGTON, Sept. 19 -- Sen. Richard J. Durbin, D-Illinois, chairman of the Senate Judiciary Committee, issued the following news release:
U.S. Senate Majority Whip Dick Durbin (D-IL), Chair of the Senate Judiciary Committee, led a group of five Senate Democrats in sending a letter to the U.S. Patent and Trademark Office (USPTO) Director Kathi Vidal regarding recent research that found pharmaceutical companies may be benefitting from errors in USPTO's calculation of patent term . . .
U.S. Senate Majority Whip Dick Durbin (D-IL), Chair of the Senate Judiciary Committee, led a group of five Senate Democrats in sending a letter to the U.S. Patent and Trademark Office (USPTO) Director Kathi Vidal regarding recent research that found pharmaceutical companies may be benefitting from errors in USPTO's calculation of patent term . . .